The HIV vaccine testing in humans that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.
- What is an Option Chain and How to Read it?
- Piramal Pharma Shares Gained 11% On Release of Strong Q4FY24 Results
- TVS Motors Shares Traded 2% Higher On Introducing Variants to iQube Electric Vehicles
- Kotak Mahindra Bank Shares Bought by 39 Mutual Fund Houses, Shares Traded Flat
- India Infradebt Plans To Raise Rs 1,000 Crores Through Bonds
This Phase 1 trial is being carried out in the United States among 56 healthy adults who are HIV negative.
Despite four decades of research, doctors have yet to develop a vaccine to protect people from the virus that causes AIDS, which kills hundreds of thousands of people around the world each year.
But hopes have been stirred with the success of mRNA technology, which allowed for the development of Covid-19 vaccines in record time, including one from Moderna.